论文部分内容阅读
Zevalin关键词:滤泡淋巴瘤欧盟人用药品委员会(CHMP)近日建议批准拜耳先灵制药放射免疫调节剂Zevalin([90Y]-ibritumomab tiuxetan)用于滤泡淋巴瘤的治疗。Zevalin先前已被批准用于滤泡B细胞非霍奇金淋巴瘤的治
Zevalin Keywords: Follicular lymphoma European Commission on Human Products (CHMP) recently recommended the approval of Bayer Schering Pharma radioimmunocontrol Zevalin ([90Y] -ibitumomab tiuxetan) for the treatment of follicular lymphoma. Zevalin has previously been approved for the treatment of follicular B cell non-Hodgkin’s lymphoma